褪黑素
氧化应激
免疫系统
活性氧
抗氧化剂
炎症
活性氮物种
巨噬细胞
先天免疫系统
免疫学
癌症
癌细胞
生物
线粒体
氧化磷酸化
超氧化物
化学
药理学
谷胱甘肽
癌症治疗
癌症研究
细胞生物学
医学
获得性免疫系统
作者
Elena Lavado-Fernández,Cristina Pérez‐Montes,Miguel Robles-García,Adrián Santos‐Ledo,Marina García Macia
出处
期刊:Antioxidants
[Multidisciplinary Digital Publishing Institute]
日期:2026-01-03
卷期号:15 (1): 64-64
被引量:18
标识
DOI:10.3390/antiox15010064
摘要
Melatonin, an ancient and evolutionarily conserved indolamine, has long attracted attention for its multifunctional roles in redox homeostasis. More recently, it has been studied in relation to immune regulation and cancer biology. Beyond its well-known circadian function, melatonin modulates oxidative stress by directly scavenging reactive oxygen and nitrogen species and by upregulating antioxidant enzymes, including superoxide dismutase, catalase, and glutathione peroxidase. At the same time, it exerts wide-ranging immunomodulatory functions by influencing both innate and adaptive immune responses. All these actions converge within the tumor microenvironment, where oxidative stress and immune suppression drive cancer progression. Although the antitumoral effects of melatonin have traditionally been interpreted through its actions on T cells and NK cells, recent studies identify macrophages as an underappreciated and pivotal target. Notably, melatonin influences macrophage polarization, favoring antitumor M1 phenotypes over pro-tumoral M2 states, while attenuating chronic inflammation and restoring mitochondrial function. This review summarizes current knowledge on melatonin's antioxidant and immunoregulatory mechanisms, highlighting its impact on the tumor immune microenvironment, with a particular focus on the growing recognition of macrophages as a compelling new axis through which melatonin may exert anticancer effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI